Elucidating the gut microbiota composition and the bioactivity of immunostimulatory commensals for the optimization of immune checkpoint inhibitors

Accumulating evidence from preclinical studies and human trials demonstrated the crucial role of the gut microbiota in determining the effectiveness of anticancer therapeutics such as immunogenic chemotherapy or immune checkpoint blockade. In summary, it appears that a diverse intestinal microbiota...

Descripción completa

Detalles Bibliográficos
Autores principales: Daillère, Romain, Routy, Bertrand, Goubet, Anne-Gaëlle, Cogdill, Alexandria, Ferrere, Gladys, Alves-Costa Silva, Carolina, Fluckiger, Aurélie, Ly, Pierre, Haddad, Yacine, Pizzato, Eugenie, Thelemaque, Cassandra, Fidelle, Marine, Mazzenga, Marine, Roberti, Maria Paula, Melenotte, Cléa, Liu, Peng, Terrisse, Safae, Kepp, Oliver, Kroemer, Guido, Zitvogel, Laurence, Derosa, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466864/
https://www.ncbi.nlm.nih.gov/pubmed/32934888
http://dx.doi.org/10.1080/2162402X.2020.1794423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466864/
https://www.ncbi.nlm.nih.gov/pubmed/32934888
http://dx.doi.org/10.1080/2162402X.2020.1794423

Ejemplares similares